Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: USA Warrants, Reduced, 2025 Q4

CITADEL ADVISORS LLC historic quarter change: USA Warrants, Reduced

In warrants (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 1,717 positions, added to 870, reduced 1,219 and sold out of 1,694.

  • Q4 2025: Stock LOCAFY LIMITED; Country of operation —; Class *W EXP 03/29/202; Shares before 44,503.
  • Q4 2025: Stock GRABAGUN DIGITAL HLDGS INC; Country of operation —; Class *W EXP 99/99/999; Shares before 305,157.
  • Q4 2025: Stock BONE BIOLOGICS CORP; Country of operation —; Class *W EXP 10/13/202; Shares before 35,573.
  • Q4 2025: Stock TRISALUS LIFE SCIENCES INC; Country of operation —; Class *W EXP 08/10/202; Shares before 126,876.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q4 2025LOCAFY LIMITED
CUSIP Q56120142
—*W EXP 03/29/20244,50342,363-2,140$458,381$76,677-$381,7042026-02-17
Q4 2025GRABAGUN DIGITAL HLDGS INC
CUSIP 38387Q113
—*W EXP 99/99/999305,157305,049-108$381,477$114,393-$267,0842026-02-17
Q4 2025BONE BIOLOGICS CORP
CUSIP 098070154
—*W EXP 10/13/20235,57335,323-250$355,730$547,507+$191,7772026-02-17
Q4 2025TRISALUS LIFE SCIENCES INC
CUSIP 89680M119
—*W EXP 08/10/202126,87678,283-48,593$199,195$129,167-$70,0282026-02-17
Q4 2025NUTRIBAND INC
CUSIP 67092M125
—*W EXP 99/99/999134,995119,387-15,608$229,492$192,213-$37,2792026-02-17
Q4 2025HEARTSCIENCES INC
CUSIP 42254E112
—*W EXP 06/15/202214,098195,559-18,539$29,760$8,820-$20,9402026-02-17
Q4 2025AMPLITECH GROUP INC
CUSIP 03211Q119
—*W EXP 02/26/20221,60318,122-3,481$8,777$1,452-$7,3252026-02-17
Q4 2025BIOAFFINITY TECHNOLOGIES INC
CUSIP 09076W117
—*W EXP 09/07/20230,58423,498-7,086$13,151$7,754-$5,3972026-02-17
Q4 2025ROCKET PHARMACEUTICALS INC
CUSIP 77313F114
—*W EXP 09/02/202312,789311,489-1,300$11,260$6,167-$5,0932026-02-17
Q4 2025EON RESOURCES INC
CUSIP 40472A128
—*W EXP 02/04/202129,72148,419-81,302$6,486$2,300-$4,1862026-02-17
Q4 2025BANZAI INTERNATIONAL INC
CUSIP 06682J118
—*W EXP 12/14/202191,306190,231-1,075$5,108$2,663-$2,4452026-02-17
Q4 2025ABLE VIEW GLOBAL INC
CUSIP G1149B116
—*W EXP 08/18/202251,440228,063-23,377$8,448$6,568-$1,8802026-02-17
Q4 2025CEA INDUSTRIES INC
CUSIP 86887P119
—*W EXP 02/11/20216,86616,766-100$2,699$931-$1,7682026-02-17
Q4 2025APOLLOMICS INC
CUSIP G0411D115
—*W EXP 04/01/202105,64258,200-47,442$2,007$646-$1,3612026-02-17
Q4 2025CAPTIVISION INC
CUSIP G18932114
—*W EXP 11/15/20233,60623,117-10,489$1,344$301-$1,0432026-02-17
Q4 2025BOLT PROJS HLDGS INC
CUSIP 09769B115
—*W EXP 08/13/20231,27730,782-495$1,311$508-$8032026-02-17
Q4 2025KWESST MICRO SYSTEMS INC
CUSIP 501506133
—*W EXP 09/01/20230,26025,665-4,595$1,510$770-$7402026-02-17
Q4 2025NEXTPLAT CORP
CUSIP 68557F118
—*W EXP 06/02/20212,96612,148-818$528$1,062+$5342026-02-17
Q4 2025JEFFS BRANDS LTD
CUSIP M61472110
—*W EXP 99/99/99928,09327,956-137$840$313-$5272026-02-17
Q4 202560 DEGREES PHARMACEUTICALS I
CUSIP 83006G112
—*W EXP 07/12/20220,79515,574-5,221$769$978+$2092026-02-17
Q4 2025COEPTIS THERAPEUTICS HLDGS I
CUSIP 19207A116
—*W EXP 10/28/20210,05910,023-36$300$107-$1932026-02-17
Q4 2025XOS INC
CUSIP 98423B116
—*W EXP 08/20/20215,85515,219-636$165$59-$1062026-02-17
Q4 2025AUDDIA INC
CUSIP 05072K115
—*W EXP 02/19/20272,69769,586-3,111$1,636$1,705+$692026-02-17
Q4 2025TENON MEDICAL INC
CUSIP 88066N113
—*W EXP 06/16/20272,33071,533-797$723$758+$352026-02-17
Q4 2025SHF HOLDINGS INC
CUSIP 824430110
—*W EXP 09/28/20215,36813,261-2,107$519$503-$162026-02-17
Q4 2025MKDWELL TECH INC
CUSIP G6209W116
—*W EXP 07/31/20235,85335,253-600$394$409+$152026-02-17
Q4 2025NEWGENIVF GROUP LIMITED
CUSIP G0544E113
—*W EXP 04/03/20229,60929,421-188$489$500+$112026-02-17